- 21. Flora
- (Bad Berka)
- ... our experience because I think other patients in the US and Canada with neuroendocrine cancers might want to consider the same treatment, which is not available in North America. Diagnosis and Prior ...
- Created on 18 April 2011
- 22. John M.
- (Bad Berka)
- As a Canadian I believe we get good average health care. But when you hear that you have neuroendocrine cancer you learn a lot fast. First of all you find out that most doctors, including oncologists know ...
- Created on 17 April 2011
- 23. Perspective on Generator-based PET radiopharmaceuticals
- (Publications)
- ... a quantitative molecular imaging diagnosis of a disease (soft tissue tumours such as neuroendocrine cancer – imaged via peptidic molecular targeting vectors, or bone diseases such as metastases – imaged ...
- Created on 11 April 2011
- 24. 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy
- (In the News)
- ... anlogue) to treat a 15-year-old boy with a rare neuroendocrine tumor, called paraganglioma, and saw the boy go from being wheelchair-bound and in terrible pain to a young man of 20 who was walking and ...
- Created on 07 April 2011
- 25. Zentralklinik Bad Berka Named ENETS Center of Excellence
- (In the News)
- January 2011 - European Neuroendocrine Tumor Society has certified Zentralklink Bad Berka as an ENETS Centers of Excellence. The certification states that center meets all quality standards defined ...
- Created on 06 April 2011
- 26. What are the Risk and Side Effects of PRRT
- (PRRT)
- What are the Risks? As with most, if not all, of the treatment options open to neuroendocrine tumor patients, there are risks associated with using PRRT to treat metastasized tumors. The greatest risks ...
- Created on 16 March 2011
- 27. Who Should Consider PRRT
- (PRRT)
- Peptide Receptor Radionuclide Therapy (PRRT) will not work on all neuroendocrine tumors. For this treatment to work you MUST have somatostatin receptors in your tumors. When a somatostatin analog (like ...
- Created on 20 January 2011
- 28. How Does PRRT Work
- (PRRT)
- Perhaps the simplest way to explain the workings of PRRT is to think about the analogy of a magnet and its ability to attract iron shavings. Think of a neuroendocrine tumor with somatostatin positive receptors ...
- Created on 20 January 2011
- 29. About this site
- (Uncategorised)
- ... Task force on Neuroendocrine Tumors. Recently Josh was elected to the board of the Education and Research Foundation for Nuclear Medicine and Molecular Imaging. Disclaimer: Any information provide ...
- Created on 20 January 2011
- 30. Information for Referring Physicians
- (General MD)
- ... positive neuroendocrine tumor patients (non-resectable disease) with the following characteristics: * A fundamental prerequisite is that high somatostatin receptor expression has been proven before PRRT ...
- Created on 19 July 2010
- 31. What is PRRT?
- (PRRT)
- ... radionuclide emitting beta radiation. PRRT is a novel nuclear medicine therapy (the first patients were treated in 1996) for the systemic treatment of metastasized neuroendocrine tumors. These types of ...
- Created on 19 July 2010
- 32. Zentralklinik Team
- (Background)
- ... (Head: Dr. J. Leonardi and Dr. A. Petrovitch). All departments work together as a team on neuroendocrine tumors. The Centre supports interdisciplinary pain management (led by Dr. J. Lutz) and the Department ...
- Created on 19 July 2010